Cargando…

Uric Acid as a Marker of Mortality and Morbidity in Fabry Disease

BACKGROUND: Serum uric acid (UA) elevation is common in patients with cardiovascular, renal and metabolic diseases. However, no study to date has analysed the role of UA in Fabry disease (FD). OBJECTIVES: To evaluate the association between serum UA levels and mortality and morbidity in FD. MATERIAL...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rob, Daniel, Marek, Josef, Dostálová, Gabriela, Goláň, Lubor, Linhart, Aleš
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5105940/ https://www.ncbi.nlm.nih.gov/pubmed/27835692 http://dx.doi.org/10.1371/journal.pone.0166290

Ejemplares similares

Correction: Uric Acid as a Marker of Mortality and Morbidity in Fabry Disease
por: Rob, Daniel, et al.
Publicado: (2017)

Heart failure in Fabry disease revisited: application of current heart failure guidelines and recommendations
por: Rob, Daniel, et al.
Publicado: (2022)

Serum Bilirubin Levels and Promoter Variations in HMOX1 and UGT1A1 Genes in Patients with Fabry Disease
por: Jirásková, Alena, et al.
Publicado: (2017)

Three-dimensional echocardiographic left ventricular strain analysis in Fabry disease: correlation with heart failure severity, myocardial scar, and impact on long-term prognosis
por: Marek, Josef, et al.
Publicado: (2023)

Normative reference ranges for echocardiographic chamber dimensions in a healthy Central European population: results from the Czech post-MONICA survey
por: Marek, Josef, et al.
Publicado: (2019)

Evaluation of the efficacy and safety of three dosing regimens of agalsidase alfa enzyme replacement therapy in adults with Fabry disease
por: Goláň, Lubor, et al.
Publicado: (2015)

Nationwide screening of Fabry disease in patients with hypertrophic cardiomyopathy in Czech Republic
por: Zemánek, David, et al.
Publicado: (2022)

The coincidence of IgA nephropathy and Fabry disease
por: Maixnerová, Dita, et al.
Publicado: (2013)

Nationwide screening for Fabry disease in unselected stroke patients
por: Tomek, Aleš, et al.
Publicado: (2021)

Serum Bilirubin and Markers of Oxidative Stress and Inflammation in a Healthy Population and in Patients with Various Forms of Atherosclerosis
por: Vítek, Libor, et al.
Publicado: (2022)

The Urinary Uric Acid / Cr ratio as a marker of morbidity and mortality of preterm infants: a case—control study
por: Sadeghzadeh, Mansour, et al.
Publicado: (2021)

Safety and efficacy of pegunigalsidase alfa in patients with Fabry disease who were previously treated with agalsidase alfa: results from BRIDGE, a phase 3 open-label study
por: Linhart, Aleš, et al.
Publicado: (2023)

Left ventricular hypertrophy in Fabry disease: a practical approach to diagnosis
por: Yousef, Zaheer, et al.
Publicado: (2013)

Replacement of α-galactosidase A in Fabry disease: effect on fibroblast cultures compared with biopsied tissues of treated patients
por: Keslová-Veselíková, Jana, et al.
Publicado: (2008)

Erectile Dysfunction in Young Myocardial Infarction Survivors: Evaluation, Follow Up
por: Dostálová, Gabriela, et al.
Publicado: (2017)

Time to treatment benefit for adult patients with Fabry disease receiving agalsidase β: data from the Fabry Registry
por: Ortiz, Alberto, et al.
Publicado: (2016)

Association of serum uric acid level with mortality and morbidity of patients with acute ST-elevation myocardial infarction
por: Hajizadeh, Reza, et al.
Publicado: (2016)

Renoprotective Effect of Agalsidase Alfa: A Long-Term Follow-Up of Patients with Fabry Disease
por: Cybulla, Markus, et al.
Publicado: (2022)

Prompt Agalsidase Alfa Therapy Initiation is Associated with Improved Renal and Cardiovascular Outcomes in a Fabry Outcome Survey Analysis
por: Hughes, Derralynn, et al.
Publicado: (2021)

Uric Acid—An Emergent Risk Marker for Thrombosis?
por: Țăpoi, Laura, et al.
Publicado: (2021)

Uric Acid as a Marker of Kidney Disease: Review of the Current Literature
por: Giordano, Christin, et al.
Publicado: (2015)

Phenotypic characteristics of the p.Asn215Ser (p.N215S) GLA mutation in male and female patients with Fabry disease: A multicenter Fabry Registry study
por: Germain, Dominique P., et al.
Publicado: (2018)

Cut-Off Value of Serum Uric Acid for Development of Gout Disease in Patients with Multiple Co-Morbidities
por: Ulutaş, Firdevs, et al.
Publicado: (2021)

Urinary Uric Acid/Creatinine Ratio as a Marker of Mortality and Unfavorable Outcome in NICU-Admitted Neonates
por: Nariman, Shahin, et al.
Publicado: (2016)

Assessment of Asymptomatic Severe Aortic Regurgitation by Doppler-Derived Echo Indices: Comparison with Magnetic Resonance Quantification
por: Hlubocká, Zuzana, et al.
Publicado: (2021)

Contribution of uric acid to cancer risk, recurrence, and mortality
por: Fini, Mehdi A, et al.
Publicado: (2012)

Uric acid and cardiometabolic diseases
por: Lee, Seung Jae, et al.
Publicado: (2020)

Serum Uric Acid and Kidney Disease Measures Independently Predict Cardiovascular and Total Mortality: The Uric Acid Right for Heart Health (URRAH) Project
por: Russo, Elisa, et al.
Publicado: (2021)

Uric Acid and Risk of Cardiovascular Disease and Mortality: A Longitudinal Cohort Study
por: Kim, Jae Young, et al.
Publicado: (2023)

Level of uric acid and uric acid/creatinine ratios in correlation with stage of Parkinson disease
por: Zhong, Ling-Ling, et al.
Publicado: (2018)

Uric acid albumin ratio as a predictive marker of short-term mortality in patients with acute kidney injury
por: Özgür, Yasemin, et al.
Publicado: (2021)

Urine Bikunin as a Marker of Renal Impairment in Fabry's Disease
por: Lepedda, Antonio Junior, et al.
Publicado: (2013)

Uric Acid
Publicado: (1900)

Uric Acid
Publicado: (1898)

Serum Uric Acid and Mortality Risk Among Hemodialysis Patients
por: Zawada, Adam M., et al.
Publicado: (2020)

Association between serum uric acid level and mortality in China
por: Chang, Dong-Yuan, et al.
Publicado: (2021)

Fabry disease
por: Germain, Dominique P
Publicado: (2010)

Association of uric acid and uric acid to creatinine ratio with chronic kidney disease in hypertensive patients
por: Silva, Nathalia Rabello, et al.
Publicado: (2021)

Uric Acid as a Factor of Disease
por: Van Goidtsnoven, E.
Publicado: (1895)

Cardiac abnormalities in Anderson-Fabry disease and Fabry’s cardiomyopathy
por: Morrissey, Ryan P, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_pde5b7phh1oqc0vciiklboqkpp